Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study

Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV transmission in people at high risk of HIV acquisition. PrEP is highly efficacious when taken either daily, or in an on-demand schedule. In Australia co-formulated tenofovir-emtricitabine is register...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Public Health
Autors principals: Ryan, Kathleen E., Mak, Anne, Stoove, Mark, Price, Brian, Fairley, Christopher K., Ruth, Simon, Lal, Luxshimi, Asselin, Jason, El-Hayek, Carol, Nguyen, Long, Batrouney, Colin, Wilson, David, Lockwood, John, Murphy, Dean, Cornelisse, Vincent J., Roth, Norman, Willcox, Jeff, Chang, Christina C., Armishaw, Judy, Tee, Ban K., Penn, Matthew, Forgan-Smith, George, Williams, Christopher, Montgomery, Jeff, Byron, Kat, Coelho, Alison, Allen, Brent, Wiggins, Jeremy, Kelsall, Jenny, Vujovic, Olga, West, Michael, Pierce, Anna B., Gallant, Daniel, Bell, Charlotte, de Wit, John B. F., Hoy, Jennifer F., Wesselingh, Steve L., Grant, Robert M., Wright, Edwina J.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Public Health
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5987055/
https://ncbi.nlm.nih.gov/pubmed/29896468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2018.00151
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars